Published in Medical Device Law Weekly, November 23rd, 2008
"Restorelle(TM) Y was developed with the needs of our surgeons and patients in mind," stated Ian Stevens, Chief Executive Officer, Mpathy Medical. "We are confident this product delivers upon our mission to offer less invasive surgical mesh solutions which yield better outcomes for patients."
Restorelle(TM) Y...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.